CH627469A5 - Procede de preparation de nouveaux derives d'oxepane. - Google Patents

Procede de preparation de nouveaux derives d'oxepane. Download PDF

Info

Publication number
CH627469A5
CH627469A5 CH1401977A CH1401977A CH627469A5 CH 627469 A5 CH627469 A5 CH 627469A5 CH 1401977 A CH1401977 A CH 1401977A CH 1401977 A CH1401977 A CH 1401977A CH 627469 A5 CH627469 A5 CH 627469A5
Authority
CH
Switzerland
Prior art keywords
methyl
nonenyl
dimethyl
hydroxy
oxepan
Prior art date
Application number
CH1401977A
Other languages
English (en)
French (fr)
Inventor
Ramesh Kanojia
Michael Wachter
Robert Chen
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of CH627469A5 publication Critical patent/CH627469A5/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02Seven-membered rings
    • C07D313/04Seven-membered rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH1401977A 1976-11-18 1977-11-16 Procede de preparation de nouveaux derives d'oxepane. CH627469A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/742,940 US4102895A (en) 1976-11-18 1976-11-18 Oxepanes

Publications (1)

Publication Number Publication Date
CH627469A5 true CH627469A5 (fr) 1982-01-15

Family

ID=24986860

Family Applications (3)

Application Number Title Priority Date Filing Date
CH1401977A CH627469A5 (fr) 1976-11-18 1977-11-16 Procede de preparation de nouveaux derives d'oxepane.
CH75181A CH629793A5 (fr) 1976-11-18 1981-02-04 Procede de preparation de nouveaux derives de l'oxepane.
CH75081A CH629792A5 (fr) 1976-11-18 1981-02-04 Procede de preparation de nouveaux derives de l'oxepane.

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH75181A CH629793A5 (fr) 1976-11-18 1981-02-04 Procede de preparation de nouveaux derives de l'oxepane.
CH75081A CH629792A5 (fr) 1976-11-18 1981-02-04 Procede de preparation de nouveaux derives de l'oxepane.

Country Status (15)

Country Link
US (1) US4102895A (https=)
JP (1) JPS5365890A (https=)
AT (1) AT363478B (https=)
AU (1) AU516476B2 (https=)
CA (1) CA1113478A (https=)
CH (3) CH627469A5 (https=)
DE (1) DE2751396A1 (https=)
FR (1) FR2371443A1 (https=)
GB (1) GB1594100A (https=)
GR (1) GR63241B (https=)
IE (1) IE45915B1 (https=)
IL (1) IL53420A (https=)
NZ (1) NZ185641A (https=)
PH (1) PH13596A (https=)
ZA (1) ZA776879B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182717A (en) * 1978-06-29 1980-01-08 Ortho Pharmaceutical Corp. Total synthesis of the utero-evacuant substance d,l-zoapatanol
US4177194A (en) * 1978-06-29 1979-12-04 Ortho Pharmaceutical Corporation Total synthesis of the utero-evacuant substance D,L-zoapatanol
US4256644A (en) * 1978-12-18 1981-03-17 Ortho Pharmaceutical Corporation Chemical intermediates in the preparation of oxepane compounds
US4215048A (en) * 1979-05-18 1980-07-29 Ortho Pharmaceutical Corporation Total synthesis of (1RS, 4SR, 5RS)-4-(4,8-dimethyl-5-hydroxy-7-nonenyl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
US4237054A (en) * 1979-05-18 1980-12-02 Ortho Pharmaceutical Corporation Total synthesis of (1RS,4SR,5RS)-4-(4,8-dimethyl-5-hydroxy-7-nonenyl)-4-methyl-3,8-dioxabicyclo[3.2.1] octane-1-acetic acid
US4237055A (en) * 1979-06-18 1980-12-02 Ortho Pharmaceutical Corporation Synthesis of 1RS,4SR,5RS-4-(4,8-dimethyl-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
US4322353A (en) * 1980-04-18 1982-03-30 Ortho Pharmaceutical Corporation Synthesis of dioxabicyclo(3.2.1)octanes and oxepanes
US4284565A (en) * 1980-05-02 1981-08-18 Ortho Pharmaceutical Corporation Total synthesis of 1RS,4SR,5RS-4-(4,8-dimethyl)-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid and related compounds
US4329288A (en) * 1980-05-02 1982-05-11 Ortho Pharmaceutical Corporation (1RS,4SR,5RS)-4-(5-Hydroxy-4,8-dimethyl-8-nonenyl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
KR850000218B1 (ko) * 1980-07-31 1985-03-06 오오소오 화아마슈이티갈 코오포레이숀 디옥사비시클로[3.2.1]옥탄 유도체의 합성방법
US4277401A (en) * 1980-08-25 1981-07-07 Ortho Pharmaceutical Corporation Total synthesis of 1RS,4SR,5RS-4-(4,8-dimethyl)-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
US4307019A (en) * 1980-08-25 1981-12-22 Ortho Pharmaceutical Corporation Total synthesis of 1RS,4SR,5RS,-4-(4,8-dimethyl-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
US4322357A (en) * 1981-02-23 1982-03-30 Ortho Pharmaceutical Corporation Novel cycloheptanes
US4360467A (en) * 1981-02-23 1982-11-23 Ortho Pharmaceutical Corporation Process for preparing 8-oxabicyclo[3.2.1]-octane-1-acetic acids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2515670C2 (de) * 1975-04-10 1985-07-25 Ortho Pharmaceutical Corp., Raritan, N.J. Verfahren zum Isolieren von Substanzen mit uteroevakuierender Wirkung aus der Zoapatl-Pflanze und diese Substanzen enthaltende Arzneimittel

Also Published As

Publication number Publication date
US4102895A (en) 1978-07-25
DE2751396A1 (de) 1978-05-24
IE45915L (en) 1978-05-18
FR2371443A1 (fr) 1978-06-16
CH629792A5 (fr) 1982-05-14
NZ185641A (en) 1984-08-24
JPS5365890A (en) 1978-06-12
JPS625154B2 (https=) 1987-02-03
ATA824077A (de) 1981-01-15
AU3072977A (en) 1979-05-24
AU516476B2 (en) 1981-06-04
CA1113478A (en) 1981-12-01
CH629793A5 (fr) 1982-05-14
GB1594100A (en) 1981-07-30
ZA776879B (en) 1979-06-27
FR2371443B1 (https=) 1984-02-24
AT363478B (de) 1981-08-10
GR63241B (en) 1979-10-12
IE45915B1 (en) 1982-12-29
IL53420A0 (en) 1978-01-31
PH13596A (en) 1980-08-05
IL53420A (en) 1983-05-15

Similar Documents

Publication Publication Date Title
CH627469A5 (fr) Procede de preparation de nouveaux derives d'oxepane.
Parker et al. Total synthesis of dl-avenaciolide
MC1475A1 (fr) Procede de preparation de derives de la purine a action anti-virale
CH647531A5 (fr) Derives alkyl-cetohexopyranosides.
CH637409A5 (fr) Steroides, leur preparation et composition therapeutique les contenant.
EP0557404A1 (fr) UTILISATION ANTIVIRALE DE COMPOSE 2,6-DI-t-BUTYLPHENOL SUBSTITUE EN POSITION 4, NOTAMMENT VIS-A-VIS DES VIRUS DE L'HERPES ET DES PAPILLOMAVIRUS.
FR2548666A1 (fr) Nouveaux derives du nor-tropane et du granatane, leur procede de preparation et leur application en therapeutique
CH641347A5 (fr) Alcool beta,gamma-dihydropolyprenylique, procede pour sa preparation et composition pharmaceutique hypotensive contenant cet alcool.
BE1004995A3 (fr) Nouveau derive de 5h-benzodiazepine, compositions pharmaceutiques le contenant et procede pour les preparer.
US4112078A (en) Isolation of uteroevacuant substances from plant extracts
EP0089894A1 (fr) (Benzimidazolyl-1)-1,N-((hydroxy-4 méthoxy-3 phényl)-2 hydroxy-2 éthyl) amino-3 butane et ses sels et hydrates à activité bêta-adrénergique, leurs applications thérapeutiques, et procédé pour les préparer
EP0066475B1 (en) Pharmaceutical composition for use in inducing cytoprotection
US4127651A (en) Isolation of uteroevacuant substances from plant extracts
IE45612B1 (en) Isolation of utero-evacuant substances from plant extracts
CA1112650A (en) Isolation of uteroevacuant substances from plant extracts
IE45990B1 (en) Isolation of utero-evacuant substances from plant extracts
CA1326675C (fr) Derives trieniques de structure chromenique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
DE2842418A1 (de) Indol-verbindungen
Milbert et al. Hypotensive phospholipids. Some stable analogs of darmstoff
BE884145R (fr) Composes indoliques nouveaux
MC1848A1 (fr) Derives de l'isoprene
CA1063941A (en) Utero-evacuant extracts from plant substances
FR2510584A1 (https=)
FR283M (fr) Médicament a base de 7 alpha, 17-diméthyltestostérone, pour le traitement thérapeutique hormonal.
BE890773A (fr) 6h-dibenzo(b,d) pyrans substitues en position 6, compositions qui les contiennent et leur preparation

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased